Investment Q&A

Q: your take on knight going to market again to raise cash,so instead of 425,000,000 cash they will have 625,000,000 cash, but he doesn't seem to do anything with it, he has done deals but nothing major,with this war chest i am not sure i get the need to go to market again. dave

Q: After market closed today,MPH announced the sacking of D Reimer,its President & CCO effective immediately.The founder Dr.Friesen will become President & other management team members will manage operations.It reports on May 11,after close.Appears to be very bad news.Please advise of situation & effect on the stock price. Roughly it had dropped from $6.93 on April 12 to $4.88 on May 4 & then recovered to$5.44 today.Always appreciate your great services & views. As a aside SJ was up 0.77 to $49.01 today after your endorsement on May 6 afternoon.Thanks

Q: Hi 5i,

In the last proxy & general meeting shareholders were to vote on a "blank cheque" policy for preferred shares I believe. I did not see results for the vote of this. Do you know what happened?

Would preferred shares dilute the value of the current common shares?
Are they for private investors or to be listed on the stock exchange?
Do you think this is a form of a "backup" or added plan to deleverage the company faster?
Would someone like BlackRock be interested in this type of investment as opposed to buying the whole company?

Thank you, Shane

Q: What is the consensus for CXR's upcoming earnings? At $30, does the risk/reward present a time to double down?

Thanks,

Wes

Q: Hi,

Could I get your thoughts on these two companies:
1) Pacific Biosciences of California (NASDAQ:PACB)
2) Illumina (NASDAQ: ILMN)

Are there any other Canadian recommendations in BioTech?

Q: Which is cheaper, prism or savaria?
And what are the growth rates of the two?
Thanks.

Q: As a follow up to my previous question regarding Concordia's share price drop you mentioned that the drop Friday was likely due to the forecast and results from Endo Pharma (ENDP. Based on your understanding of the two companies how susceptible is Concordia to the same factors and pricing that brought down ENDP? And to what extent does their acquisition and European operations buffer Condordia from tabling similar results? Thx.

Q: Hello,

I've been reading a lot about the CXR takeout possibility. There are a lot of opinions out there but inevitably because this was not a rumour, I'm looking at it more closely as a real possibility and that CXR is in play. Regardless of all the moving parts to CXR, the short players, bad press, debt, etc., and that even without a bid to buy, CXR stands to be worth much more in the future if they can start to pay down debt based on their earnings and reporting this Friday. My question is that it looks like CXR isn't getting an offer they would like to accept and the market seems to be reacting as if there is no belief that a buyout is around the corner. Why wouldn't a viable company just make a hostile bid and get the ball rolling anyway? Could you please provide your insight on this CXR situation and on how this buyout could work here considering CXR is looking?

Thanks for your answer.

Q: Could you comment on Cipher's Q1 results?

Q: Stupid, me, I forgot to put in the company name when I asked a question, lets try it again. I bought this company about 3 weeks ago, and has been on a stswady decline ever since. I don't understand it, they are trading at about cash value and are making money. I didn't know they had done a QT transaction, I typically avoid them like the plague, how do you feel about this one, do you think I should take my lumps or hang on.

Thank you for you time and have a nice day

Auftar

Q: Concordia's share price has been sliding steadily recently which I find surprising given that the company is in play ( I assume)based on any public information that we have access to. Also with the earnings report expected in a week I would assume that the company will have paid down some of its debt. Both events I thought would be positive for the shares. So why are the shares dropping as much as they have especially if Concordia has formed a committee to evaluate possible buyers? The market is acting as if that possibility has been ruled out yet there has not been any announcements to that effect. So how does one rationalize current share performance with a possible buyout that typically would stabilize share prices? Or does the market/insiders know something that we do not know? Your thoughts please. Thx.

Q: Good morning Peter,
unless I am missing something, I was under the impression that Concordia were scheduled to release their 1st Qtr results this morning, yet I can`t find any news towards this anywhere. Can you enlighten me on this? Thank you.
Rick

Q: Thoughts on Savaria's earnings? I bought this originally as a 2.5% weight and its now 4.6% of my portfolio with its stellar performance.

Q: I purchased 50 shares of ENL at 36.5 Canadian considering it was very cheap on a valuation basis. Looking at their earnings they will be earning almost US 4.9 per share in 2016. After hours the stock is down to USD 20. This price makes it around 5 times earnings. Do you suggest I bail out at the market in the morning or should I keep holding for next several months for the price to recover.

Q: PLI went down nearly 7 1/2% today, and I suppose the bought deal must be the problem. Can you enlighten me as to just how a bought deal affects the share price in the short term?
Thanks.

Q: I own half Nhc and half Hlth which is the same stovk but on the U.S. exchange. I notice that the U.S. versiob isn't going up as much as the canadian one percentage wise. How can This be?

Q: Hi Peter and Gang,
I currently have a 200% gain on PLI and my PLI position now represents about 3% of my portfolio. I am thinking of taking some money off the table and would like to get your comments on PLI. Thanks.

Harry

Q: Please comment TH

THANKS

WAI

Q: Hello Team,
Would you prefer Pfizer or Bristol Myers in this space, or, given the electioneering going on in the U.S. would something like Walgreens be your preference in the Health Care space?
Thank You,
Barry

Q: WHAT IS YOUR VIEW ABOUT THIS CO. GOING FORWARD.